Welcome to Crene Biotechnology!

+86-576-88205808

The addition of SDX-7320, a novel inhibitor of methionine aminopeptidase 2, to palbociclib was found to inhibit MCF-7 tumor growth and reduce the expression of proteins associated with resistance to palbociclib. The addition of SDX-7320, a novel inhibitor o..
Secukinumab rarely leads to latent tuberculosis infection as a reported adverse event and is supported for use in treating chronic systemic inflammatory conditions. Secukinumab (Cosentyx) is not associated with increased risk of tuberculosis (TB) reactivation ..
Daratumumab appears to be safe when used as consolidation therapy in patients with multiple myeloma, even soon after autologous stem cell transplant, and the agent has also demonstrated early efficacy in the setting of very good responders. Daratumumab (Dar..
TORONTO, March 10, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it has achieved a water solubilized selamectin product using its patent-pending Quickso..
Through a partnership with Merck, Samsung Bioepis adds to its portfolio of biosimilars available in Australia.Samsung Bioepis, of Incheon, Republic of Korea, is reporting that its adalimumab biosimilar Hadlima has been launched in Australia. The agent referenc..
A post-hoc analysis of the AWARD-11 trial indicates that 4.5 mg of dulaglutide was effective in lowering and maintaining A1C levels <7% regardless of baseline levels.diabetesJuan Pablo Frias, MDA post-hoc analysis of the AWARD-11 trial showed that higher do..
Treatment of operable non-small cell lung cancer (NSCLC) with neoadjuvant nivolumab plus ipilimumab resulted in higher complete pathologic response (cPR) rates and less viable tumor compared with treatment with nivolumab alone and chemotherapy, according to re..
As part of an industry-wide assessment of indications based on accelerated approval, Roche in consultation with the FDA has decided to withdraw the indication for atezolizumab in patients with urothelial carcinoma following platinum-based chemotherapy.The indi..
This article was originally published here Am J Clin Oncol. 2021 Feb 22. doi: 10.1097/COC.0000000000000799. Online ahead of print. ABSTRACT OBJECTIVE: The objective of this study was to review real-world patterns of chemotherapy utilization among patien..
首页上一页当前第6/9页共78条记录每页9条45678下一页尾页
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China